Gilead Sciences Inc.
Gilead Sciences Inc. (GILD) — Form 144: Proposed sale of shares
AI-generated summary
ANDREW DICKINSON, Officer of Gilead Sciences, Inc., proposed to sell 3,000 shares of Common stock with an aggregate market value of $468,660 through Morgan Stanley Smith Barney LLC Executive Financial Services on October 15, 2026. The shares were originally acquired as Performance Shares on January 31, 2024. The proposed sale is associated with a trading plan adopted on August 29, 2024.
Key facts
- Seller
- ANDREW DICKINSON
- Relationship
- Officer
- Shares to sell
- 3,000
- Market value
- $468,660.00
- Approximate sale date
- Oct 15, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Jan 31, 2024 · Performance Shares
Rule 10b5-1 plan · adopted Aug 29, 2024
More GILD filings
- 144
Filed Oct 30, 2026
- 8-K
Filed Oct 29, 2026
- 4
Filed Oct 16, 2026
- 4
Filed Oct 16, 2026
- 144
Filed Oct 15, 2026
- 4
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.